|
CEO letter to shareholders.
|
4
|
Pluristem Life Systems, Inc.
|
Sep 22, 2011 12:17PM
|
|
New research recommendation
|
3
|
Pluristem Life Systems, Inc.
|
Jan 06, 2012 03:57PM
|
|
Pluristem Therapeutics Set to Enter Bone Marrow Disease Market as it is Preparin
|
3
|
Pluristem Life Systems, Inc.
|
Jul 23, 2012 08:57AM
|
|
Scaling up the BIOREACTORS
|
2
|
Pluristem Life Systems, Inc.
|
Mar 13, 2012 10:19PM
|
|
Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in Intermitten
|
2
|
Pluristem Life Systems, Inc.
|
Apr 17, 2012 09:37AM
|
|
Cardiac Function in Pre-Clinical Diabetic Diastolic Heart Failure Improves with
|
2
|
Pluristem Life Systems, Inc.
|
May 15, 2012 09:37AM
|
|
Pluristem in Talks With Drugmakers on PLX-PAD Licensing ,from Bloomberg.com
|
2
|
Pluristem Life Systems, Inc.
|
Jun 19, 2012 09:49PM
|
|
Third Critically Ill Patient Successfully Treated
|
2
|
Pluristem Life Systems, Inc.
|
Sep 05, 2012 08:04AM
|
|
Just wondering
|
2
|
Pluristem Life Systems, Inc.
|
Sep 09, 2013 10:51PM
|
|
New article on TD Ameritrade
|
2
|
Pluristem Life Systems, Inc.
|
Mar 21, 2012 09:56AM
|
|
New Seeking Alpha article by Ray Dirks
|
2
|
Pluristem Life Systems, Inc.
|
Mar 21, 2012 10:18AM
|
|
Company press release.
|
1
|
Pluristem Life Systems, Inc.
|
Nov 03, 2011 12:20PM
|
|
PSTI files S-3 with SEC.
|
1
|
Pluristem Life Systems, Inc.
|
Oct 04, 2011 04:33PM
|
|
Re: PSTI files S-3 with SEC.
|
1
|
Pluristem Life Systems, Inc.
|
Oct 05, 2011 08:46PM
|
|
Another positive Seeking Alpha article.
|
1
|
Pluristem Life Systems, Inc.
|
Mar 23, 2012 12:44PM
|
|
Pluristem Forms Peripheral Artery Disease Steering Committee
|
1
|
Pluristem Life Systems, Inc.
|
Apr 03, 2012 05:17PM
|
|
Re: Seekingalpha article.
|
1
|
Pluristem Life Systems, Inc.
|
Oct 10, 2011 04:39PM
|
|
CEO letter to the shareholders today 11-22
|
1
|
Pluristem Life Systems, Inc.
|
Nov 22, 2011 10:50AM
|
|
Today's News, May 22, 2012 TD AMERITRADE
|
1
|
Pluristem Life Systems, Inc.
|
May 22, 2012 10:26AM
|
|
Re: Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in Intermitten
|
1
|
Pluristem Life Systems, Inc.
|
Apr 19, 2012 09:24PM
|
